Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Dilutive issuance
confidence 95%
filed 2026-07-22
The 6-K discloses the closing of a PIPE (private investment in public equity) offering on July 21, 2026, in which the Company issued 45,306,732 restricted common shares to an unaffiliated investor at US$0.46667 per share for gross proceeds of US$21,145,961. The newly issued shares represent approximately 34.51% of total voting power post-closing, constituting a highly dilutive equity issuance. This is a material capital-raising event that would significantly affect a reasonable investor's assessment of ownership and control.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-22
Item 3.02
Stone Point Credit Income Fund issued 167,749.797 common shares at NAV of $24.6200 for an aggregate offering price of $4,130,000 pursuant to subscription agreements with accredited investors, exempt from registration under Section 4(a)(2) and Regulation D Rule 506. This is a classic unregistered private placement of equity securities disclosed under Item 3.02, fitting the dilutive_issuance category. The disclosure of remaining unfunded capital commitments of $776.75 million indicates ongoing capital raising activity material to investors.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-22
Item 1.01
DarioHealth entered into a Securities Purchase Agreement on July 22, 2026, to issue 2,437,060 shares of common stock and 1,017,499 pre-funded warrants in a registered direct offering at $6.80 per share, raising approximately $23.5 million in gross proceeds. This registered direct offering dilutes existing shareholders and represents a significant capital raise.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-22
Item 3.02
Nth Cycle Inc. conducted unregistered sales of equity securities to PIPE investors pursuant to Stock Purchase Agreements in reliance on Section 4(a)(2) exemption, with up to $100 million committed ($40 million to date) as part of the business combination transaction.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-22
Item 3.02
The Company sold 1,029,197 Class I common shares for $24.9 million in aggregate consideration to accredited investors pursuant to Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-22
Item 8.01
Dyne Therapeutics announced the pricing of an upsized $375 million public offering of 18.3 million shares of common stock at $20.50 per share, with underwriters holding a 30-day option to purchase an additional 2.745 million shares.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-22
Item 1.01
SunPower entered into settlement agreements on July 17, 2026 to settle OTC Equity Prepaid Forward Transactions by issuing an aggregate of 17,900,462 shares of common stock (Initial FPA Shares), with potential for additional shares issuable based on trading price during a valuation period. The shares were issued unregistered under Section 4(a)(2) exemption with registration rights granted to recipients, representing a material dilutive equity issuance and significant capital structure change.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-22
Item 3.02
Apex Treasury Corp issued $35 million in unregistered PIPE shares at $10.00 per share to a PIPE investor in connection with the TECfusions business combination, representing a dilutive equity issuance under Section 4(a)(2) of the Securities Act.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-07-22
Item 1.01
CID HoldCo entered into a Securities Purchase Agreement on July 22, 2026, to issue convertible preferred stock (Series AA and Series B) for $6.0 million aggregate purchase price. The convertible preferred stock is convertible into common shares, and the transaction requires stockholder approval for the issuance of the Conversion Shares, with restricted account mechanisms and board designation rights typical of PIPE-like transactions.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-07-22
EX-99.1
This press release announces a non-binding term sheet for a PIPE (private investment in public equity) financing in which the Buyer intends to subscribe for securities with consideration of approximately 3,500 Bitcoin. The transaction also contemplates a control transition whereby the Buyer would designate a majority of the board of directors. This is a dilutive equity issuance to a private investor that would materially affect shareholder ownership and control, making it a material disclosure under the dilutive_issuance category.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-07-22
The 6-K discloses a private placement of 23,000,000 new ordinary shares at KRW 1,600 per share (total KRW 36.8 billion / HKD 194.7 million) to three named subscribers, subject to shareholder approval at an Extraordinary General Meeting on August 6, 2026. This is a material dilutive equity issuance that would significantly affect existing shareholders' ownership percentages and voting power.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-07-22
EX-99.1
The press release announces entry into a definitive agreement for a PIPE (Private Investment in Public Equity) transaction involving the issuance of 40,000,000 Class A Ordinary Shares at US$2.0 per share for an aggregate purchase price of US$16,000,000 to 9 non-U.S. investors. The shares are issued in a private placement exempt from Securities Act registration under section 4(a)(2) and Regulation S. This is a classic dilutive equity issuance that materially increases the share count (from approximately 19.6 million to 59.6 million Class A shares post-closing) and would significantly affect a reasonable investor's assessment of ownership dilution and capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 94%
filed 2026-07-22
Item 1.01
China Pharma entered into a securities purchase agreement and announced the pricing of a registered direct offering of 2.5 million shares of common stock at $2.00 per share, generating $5 million in gross proceeds. The offering includes investor participation rights in future financings and materially dilutes existing shareholders' ownership percentages.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-07-22
The filing discloses completion of a Series A Rights Offering that raised approximately $21.9 million and will result in issuance of approximately 4,384,163 shares of common stock. This is a material capital-raising event involving dilutive equity issuance to existing shareholders through a rights offering, which materially affects the registrant's capitalization and shareholder ownership percentages.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-07-22
The filing discloses multiple unregistered equity issuances in a short timeframe: (1) 500,000 commitment fee shares to Hollywood Horizons; (2) warrants to purchase up to 6,891,798 shares initially and up to 50,000,000 shares total under the warrant purchase agreement with GL PART SPV II, LLC; and (3) 6,666,667 shares sold to Lombard Street Partners, LLC. Item 3.02 explicitly confirms reliance on Section 4(a)(2) and Regulation D exemptions. These private placements and warrant issuances are highly dilutive to existing shareholders and represent material capital-raising activity typical of small-cap issuers under financial stress.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-22
Item 3.02
Hawkeye Systems issued Common Stock Purchase Warrants to 15 accredited investors granting rights to purchase 14,000,000 shares of common stock at $.01 per share, with the warrants exercisable through December 31, 2026. The securities were offered in reliance on Section 4(a)(2) exemption and were unregistered, which is the hallmark of a private placement. This represents a dilutive issuance of equity securities outside the registered offering process, material to investors assessing capital structure and ownership dilution.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-22
Item 3.02
The Company disclosed an unregistered sale of approximately 1,168,937 common shares for ~$29 million pursuant to subscription agreements with accredited investors, relying on Section 4(a)(2) and Regulation D exemptions. This is a classic dilutive equity issuance under Item 3.02, material to investors assessing capital structure and ownership dilution.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-22
Item 3.02
The filing discloses an unregistered sale of 3,000,000 shares of common stock at $0.01 per share for $30,000 in aggregate proceeds under Section 4(a)(2) exemption. This is a classic private placement dilutive issuance. The low price per share ($0.01) and reliance on the accredited investor exemption are typical markers of a PIPE or private equity raise at a small-cap company, which would materially affect shareholder ownership and capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-21
Item 3.02
KKR FS Income Trust issued 236,760.775 Class I shares for approximately $6.882 million in an unregistered private offering relying on Section 4(a)(2) of the Securities Act and Regulation D, diluting existing shareholders' ownership.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-21
Item 3.02
The Company issued 484,782.601 Class I shares for approximately $12.042 million pursuant to a continuous private offering under Section 4(a)(2) and Regulation D to accredited investors, representing material equity dilution and capital raising activity.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-07-21
Item 8.01
FuelCell Energy filed a prospectus supplement to its automatic shelf registration statement on Form S-3, indicating a registered offering of securities. The filing of a prospectus supplement with a legal opinion on the issuance and sale of securities is the standard disclosure mechanism for equity or convertible offerings under a shelf registration, which typically results in dilution to existing shareholders. This is material to investors assessing capital structure and ownership dilution.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-21
Item 3.02
AB Private Lending Fund completed an unregistered private placement of 9,314 Class I common shares of beneficial interest to feeder vehicles, exempt under Section 4(a)(2) and Regulation S.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-21
Item 3.02
The fund conducted an unregistered private placement of 8,190,511 LLC interests for $211.6 million pursuant to Section 4(a)(2), Regulation D, and/or Regulation S exemptions, raising material capital and diluting existing investors.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-21
Item 3.02
Goldman Sachs Private Credit Corp. completed an unregistered sale of 6,097,725 Class I shares and 18,109 Class S shares totaling approximately $150.3 million. The sale was exempt from Securities Act registration under Section 4(a)(2), Regulation D, and/or Regulation S, with purchasers required to be accredited investors or non-U.S. persons.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-21
Item 3.02
EQT Private Equity Company LLC completed an unregistered sale of approximately 1.09 million shares across multiple share classes to third-party investors for aggregate cash consideration of $29.45 million as of July 1, 2026, under Section 4(a)(2) and Regulations D and S exemptions, with cumulative sales of $817.6 million since inception.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-21
Item 3.02
EQT Infrastructure Company LLC completed an unregistered sale of approximately 3.9 million equity shares across multiple classes to third-party investors for aggregate consideration of $106.2 million as of July 1, 2026, under Section 4(a)(2) and Regulations D and S. Since inception on February 1, 2026, the Company has sold approximately $817.6 million of Investor Shares as part of its continuous private offering.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-21
Item 1.01
Nuburu closed a $38.0 million public offering on July 17, 2026, issuing 117.4 million shares of common stock, 127.0 million pre-funded warrants, and 733,853 shares of Series B Preferred Stock convertible into 205.6 million additional common shares. The offering materially dilutes existing shareholders' ownership and voting power, with proceeds intended for the Tekne acquisition and debt retirement.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-07-21
Item 1.01
Virtuix amended three warrants to reduce the exercise price from $3.00 to $2.50 per share during a specified period (July 21 – August 27, 2026), making the warrants more likely to be exercised and diluting existing shareholders. While technically an amendment to existing warrants rather than a new issuance, the material reduction in exercise price substantially increases the probability of dilution and is economically equivalent to a dilutive capital event. The filing under Item 1.01 (Material Definitive Agreement) and the involvement of a significant investor (Streeterville Capital) underscore materiality.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-21
Item 3.02
The Company may issue shares of common stock to satisfy a RM2,250,000 (approximately US$550,795.60) deposit obligation under the Share Sale Agreement, with shares calculated based on currency conversion and closing price, subject to a six-month trading restriction under Regulation S.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-21
Item 3.02
AMR Resources Acquisition Corp. issued unregistered private placement units simultaneously with the IPO closing: 447,500 Sponsor Private Placement Units ($4.475M) and 260,000 Underwriter Private Placement Units ($2.6M), both pursuant to Section 4(a)(2) exemption. These dilutive private placements materially affect capitalization and investor ownership.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-07-21
The 6-K discloses completion of a July 2026 offering of 7,975,000 units and 8,525,000 pre-funded units at US$0.40 and US$0.399 per unit respectively, constituting a dilutive equity issuance. The filing explicitly states this July Offering "constitutes a Subsequent Equity Sale under the May Common Warrants," triggering downward adjustment of warrant exercise prices from US$1.30 to US$0.2333 per share—a material anti-dilution event affecting existing warrant holders and demonstrating significant equity dilution to shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-21
Item 3.02
Ares Sports, Media & Entertainment Opportunities LP completed an unregistered private placement of approximately $30.1 million in limited partnership units across multiple unit classes (Class S, Class I, Class A-S, and Class A-I) to accredited investors and qualified purchasers under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-21
Item 3.02
The Fund sold 1,203,879 Class I common shares for $32.2 million during July 2026 in an unregistered offering exempt under Section 4(a)(2) and Regulation S, raising material capital through the sale of unregistered securities at NAV pricing.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-21
Item 3.02
VisionWave Holdings disclosed an unregistered sale of convertible debentures, warrants, and shares of common stock issuable upon conversion or exercise thereof to an accredited investor in reliance on Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D, representing a classic private placement with dilutive potential to existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-21
Item 3.02
On July 21, 2026, Vivakor issued 33,000 shares to one holder and 32,000 shares to another lender upon conversion of convertible promissory notes with principal and interest totaling approximately $56,225, representing unregistered equity issuances exempt from registration under Section 4(a)(2).
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-21
Item 3.02
Ares Core Infrastructure Fund sold 45,031,717 common shares for an aggregate purchase price of $1,120.6 million in July 2026 in a private placement exempt from Securities Act registration under Section 4(a)(2) and Regulation D Rule 506(b).
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-20
Item 3.02
EWSB Bancorp closed a private placement of 88,318 shares of Series A Junior Non-Voting Participating Preferred Stock for $883,180 on July 16, 2026, concluding a rights offering to accredited investors. This is a classic dilutive issuance under Item 3.02 — an unregistered sale of equity securities that increases the company's capitalization and dilutes existing shareholders, particularly material for a small-cap bank raising capital through a preferred equity offering.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 94%
filed 2026-07-20
Item 1.01
SmartKem entered into a Securities Purchase Agreement on March 30, 2026, and amended it on July 16, 2026, to sell Series A convertible preferred stock and warrants to institutional investors. The offering raised approximately $17.1 million and includes warrants to purchase approximately 36.7 million shares of common stock, materially diluting existing shareholders upon conversion and exercise.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-07-20
EX-99.1
The exhibit discloses the exercise of 1,015,511 warrants by Kreos Capital VII Aggregator SCSp, resulting in the issuance of 577,237 new shares through a net exercise mechanism. This represents a dilutive equity issuance tied to a financing arrangement (warrant agreement dated December 23, 2025). The registration of these shares with the Finnish Trade Register increases the total share count from approximately 262.5 million to 263,039,597 shares, materially affecting shareholder ownership percentages and voting power.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 90%
filed 2026-07-20
Item 3.02
Vulcan Infrastructure & Power Inc. completed a $39.4 million PIPE transaction consisting of $29.4 million in Class A common stock issued at $1.71 per share to institutional and insider investors (Machine Investment Group, Atlas Holdings, Conversant Capital), plus a $10 million convertible note and warrants. The company will use proceeds to redeem approximately $33 million of outstanding senior notes due October 2026.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-07-20
EX-99.1
The exhibit discloses a proposed at-the-market (ATM) offering program of up to $200 million in American Depositary Shares (ADSs) representing ordinary shares, filed with the SEC on Form F-3. This is an unregistered equity issuance that will dilute existing shareholders. The announcement explicitly states the Company expects the underlying ordinary shares to represent up to 20% of total issued shares, and the offering is subject to Hong Kong listing rule waivers. This is a material capital-raising event that would affect investor assessment of ownership dilution and the Company's financing strategy.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 85%
filed 2026-07-20
The 6-K discloses termination of an at-the-market (ATM) offering agreement with AC Sunshine Securities LLC, under which the Company had sold 3,487,171 ordinary shares (approximately 96% of the $200 million authorized offering) as of July 11, 2026. While the termination itself is the headline event, the substance is the dilutive equity issuance that occurred under the ATM program. This represents a material capital-raising activity that would affect a reasonable investor's assessment of share dilution and the Company's financing strategy.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-07-20
The 6-K discloses entry into a sales agreement on July 20, 2026, authorizing the Company to offer and sell up to $16,000,000 of Class A ordinary shares through an at-the-market (ATM) offering via Craft Capital Management LLC as sales agent. This is a dilutive equity issuance that would materially affect a reasonable investor's assessment of share dilution and capital structure, particularly for a smaller-cap issuer like Linkage Global.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-20
Item 1.01
Amesite Inc. entered into an At The Market (ATM) Offering Agreement with H.C. Wainwright & Co. on July 17, 2026, permitting the company to offer and sell shares of common stock up to a maximum aggregate offering price through an ATM mechanism. This is a classic dilutive equity issuance under Rule 415 of the Securities Act, structured as an unregistered or registered direct offering that will dilute existing shareholders. The filing explicitly discloses the 3.0% commission to the agent and the company's intent to use proceeds for general corporate purposes, which is material to investors assessing capital structure and shareholder dilution risk.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-07-20
Grande Group entered into a Share Purchase Agreement with White Lion Capital on July 16, 2026, granting the Company the right to issue up to 40,000,000 in aggregate gross purchase price of newly issued Class A ordinary shares over 36 months. This is a classic at-the-market (ATM) or equity line of credit arrangement with a pricing mechanism tied to volume-weighted average prices. The registration rights agreement requiring Form F-1/F-3 filing within 30 days confirms intent to register these shares for resale, making this a material dilutive equity issuance that would affect investor assessment of ownership dilution and capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-20
Item 3.02
TOP Financial Group issued 360,534,431 Class A Ordinary Shares resulting from cashless warrant exercise on July 19-20, 2026, relying on Section 3(a)(9) and Section 4(a)(2) exemptions from registration, with shares subject to six-month lockup restrictions.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-20
Item 3.02
The company completed a private placement of 645,000 Units to the Sponsor and Underwriter at $10.00 per unit, generating $6.45 million in gross proceeds, pursuant to Section 4(a)(2) exemption, concurrent with the IPO closing.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-07-20
Item 8.01
The filing discloses completion of an IPO of 23,000,000 units at $10.00 per unit generating $230,000,000 in gross proceeds, plus a concurrent private placement of 6,000,000 warrants for $6,000,000. While this is technically an IPO (a public offering), the structure involves unregistered warrant sales to insiders and sponsors, and the company is a blank-check SPAC with no operating business. The material capital raise through equity and warrant issuance fits the dilutive_issuance category, though an IPO completion could also be characterized as operational_other; the warrant component and sponsor involvement support the dilutive classification.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-20
The filing discloses entry into warrant inducement agreements (Item 1.01) and unregistered sales of equity securities (Item 3.02) whereby Laser Photonics issued new Series A-7 and Series A-8 warrants to purchase 5,057,144 shares of common stock in exchange for the exercise of existing warrants, raising approximately $2.5 million in gross proceeds. The new warrants are unregistered and represent a dilutive equity issuance typical of cash-strapped companies raising capital through warrant exercises and inducements.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-20
Item 3.02
The Company issued 352,000 shares of common stock in exchange for preferred stock held by an existing investor, relying on Section 3(a)(9) of the Securities Act. This is a dilutive equity issuance to an unaffiliated holder without cash proceeds to the Company. The transaction materially increases common share count and dilutes existing shareholders, which is a hallmark of the dilutive_issuance category.
View raw filing on EDGAR →